Patient Selection Criteria and Midterm Clinical Outcome for MitraClip Therapy in Patients with Severe Mitral Regurgitation and Severe Congestive Heart Failure

Abstract

The interventional implantation of an MC is a new treatment for severe MR with acceptable periprocedural risk and results in clinical improvement in the majority. Patients with end-stage heart failure and an NT-proBNP value >10 000 pg/mL have a high mortality despite MC implantation, and their treatment should be based on a very individualized decision. Based on this experience, a clinical algorithm for patient selection is proposed.